back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2024-03-26 14:27 Tx date 2023-08-14 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Holder: Moore Faster LLC (Indirect Ownership)
|
Common Shares
90 - Change in the nature of ownership
|
+1,722,614 vol |
1,722,614 | |
| Filed 2024-03-26 14:27 Tx date 2017-12-21 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Holder: Moore Faster LLC (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2024-03-26 14:27 Tx date 2023-08-14 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
90 - Change in the nature of ownership
|
-1,722,614 vol |
95,407 | |
| Filed 2024-02-15 18:01 Tx date 2024-02-14 |
$PRG
Precipitate Gold Corp. |
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$63,000
+700,000 vol $0.09 each |
1,250,000 | |
| Filed 2024-01-30 19:02 Tx date 2024-01-29 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+80,527 vol |
96,447 | |
| Filed 2024-01-25 16:14 Tx date 2024-01-18 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-43,898.82
-5,761 vol $7.62 each |
1,848,956 | |
| Filed 2024-01-25 16:14 Tx date 2024-01-17 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-68,157.97
-9,223 vol $7.39 each |
1,835,738 | |
| Filed 2024-01-22 18:12 Tx date 2024-01-18 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-52,905.66
-6,943 vol $7.62 each |
||
| Filed 2024-01-20 14:50 Tx date 2024-01-17 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-69,236.91
-9,369 vol $7.39 each |
||
| Filed 2024-01-22 18:12 Tx date 2024-01-18 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-52,905.66
-6,943 vol $7.62 each |
1,847,628 | |
| Filed 2024-01-22 18:12 Tx date 2024-01-18 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+18,979 vol |
1,854,571 | |
| Filed 2024-01-22 18:11 Tx date 2024-01-18 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-18,979 vol |
15,920 | |
| Filed 2024-01-22 18:11 Tx date 2024-01-18 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-18,979 vol |
||
| Filed 2024-01-22 18:11 Tx date 2024-01-18 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+28,228 vol |
||
| Filed 2024-01-22 18:10 Tx date 2024-01-18 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+28,228 vol |
||
| Filed 2024-01-22 18:10 Tx date 2024-01-18 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-18,979 vol |
||
| Filed 2024-01-20 14:50 Tx date 2024-01-17 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-69,236.91
-9,369 vol $7.39 each |
1,835,592 | |
| Filed 2024-01-20 14:50 Tx date 2024-01-17 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+26,940 vol |
1,844,961 | |
| Filed 2024-01-20 14:49 Tx date 2024-01-17 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-26,940 vol |
34,899 | |
| Filed 2023-11-23 17:56 Tx date 2023-11-20 |
$PRG
Precipitate Gold Corp. |
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-40,000
-500,000 vol $0.08 each |
550,000 | |
| Filed 2023-09-01 14:53 Tx date 2023-08-31 |
$NA
Northern Silicon International Inc. |
Moore, Michael Peter
3 - 10% Security Holder of Issuer
Holder: Inclination Earth Sciences Inc. (Control or Direction)
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$11,200
+1,120,000 vol $0.01 each |
1,120,000 | |
| Filed 2023-09-01 14:52 Tx date 2023-08-31 |
$NA
Northern Silicon International Inc. |
Moore, Michael Peter
3 - 10% Security Holder of Issuer
Holder: Inclination Earth Sciences Inc. (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2023-08-08 17:43 Tx date 2023-08-04 |
$SR
Strategic Resources Inc. |
Moore, Michael Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$290,000
+200,000 vol $1.45 each |
233,333 | |
| Filed 2023-04-05 16:35 Tx date 2023-03-31 |
$SR
Strategic Resources Inc. |
Moore, Michael Peter
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-166,667 vol |
33,333 | |
| Filed 2023-04-05 16:34 Tx date 2023-03-31 |
$SR
Strategic Resources Inc. |
Moore, Michael Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-950,000 vol |
190,000 | |
| Filed 2023-01-20 16:10 Tx date 2023-01-18 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-52,579.59
-6,767 vol $7.77 each |
1,818,021 | |
| Filed 2023-01-19 14:29 Tx date 2023-01-18 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+18,979 vol |
1,824,788 | |
| Filed 2023-01-19 14:29 Tx date 2023-01-18 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-18,979 vol |
61,839 | |
| Filed 2023-01-19 14:28 Tx date 2023-01-17 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+80,818 vol |
80,818 | |
| Filed 2022-11-24 13:36 Tx date 2022-11-23 |
$SR
Strategic Resources Inc. |
Moore, Michael Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$60,000
+240,000 vol $0.25 each |
1,140,000 | |
| Filed 2022-11-24 13:34 Tx date 2022-11-23 |
$SR
Strategic Resources Inc. |
Moore, Michael Peter
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
$-60,000
-240,000 vol $0.25 each |
200,000 | |
| Filed 2022-01-22 05:50 Tx date 2022-01-18 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Rights - Restricted Stock Units (Shares Only)
56 - Grant of rights
|
+56,937 vol |
56,937 | |
| Filed 2022-01-22 05:49 Tx date 2017-12-21 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Rights - Restricted Stock Units (Shares Only)
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2022-01-22 05:49 Tx date 2022-01-18 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+85,410 vol |
700,432 | |
| Filed 2021-12-31 13:48 Tx date 2017-07-21 |
$PRG
Precipitate Gold Corp. |
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-154,000 vol |
-77,000 | |
| Filed 2021-12-31 13:33 Tx date 2021-12-30 |
$PRG
Precipitate Gold Corp. |
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$7,500
+50,000 vol $0.15 each |
50,000 | |
| Filed 2021-12-31 13:32 Tx date 2021-12-30 |
$PRG
Precipitate Gold Corp. |
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$10,000
+100,000 vol $0.10 each |
649,666 | |
| Filed 2021-11-17 14:04 Tx date 2021-11-16 |
$SR
Strategic Resources Inc. |
Moore, Michael Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$31,499
+90,000 vol $0.35 each |
440,000 | |
| Filed 2021-10-20 11:58 Tx date 2021-10-18 |
$PRG
Precipitate Gold Corp. |
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$47,500
+500,000 vol $0.095 each |
1,050,000 | |
| Filed 2021-10-17 12:37 Tx date 2021-10-13 |
$PRG
Precipitate Gold Corp. |
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-50,000
-200,000 vol $0.25 each |
550,000 | |
| Filed 2021-10-17 12:36 Tx date 2021-03-04 |
$PRG
Precipitate Gold Corp. |
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-30,000
-250,000 vol $0.12 each |
750,000 | |
| Filed 2021-02-01 21:30 Tx date 2021-01-29 |
$PRG
Precipitate Gold Corp. |
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$105,000
+500,000 vol $0.21 each |
1,000,000 | |
| Filed 2021-02-01 19:13 Tx date 2021-01-29 |
$
Archer Exploration Corp. |
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
5,000 | ||
| Filed 2021-01-26 16:21 Tx date 2021-01-21 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+120,584 vol |
615,022 | |
| Filed 2021-01-08 21:23 Tx date 2021-01-05 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
-30,917 vol |
1,805,809 | |
| Filed 2021-01-08 21:23 Tx date 2021-01-05 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$780,049
+99,243 vol $7.86 each |
1,836,726 | |
| Filed 2021-01-08 21:22 Tx date 2021-01-05 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-99,243 vol |
0 | |
| Filed 2020-11-20 19:01 Tx date 2020-11-19 |
$SR
Strategic Resources Inc. |
Moore, Michael Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$40,700
+110,000 vol $0.37 each |
350,000 | |
| Filed 2020-06-26 08:59 Tx date 2020-06-23 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-10,431.63
-900 vol $11.59 each |
1,737,483 | |
| Filed 2020-06-22 18:01 Tx date 2020-06-22 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,281,701.928
-108,582 vol $11.80 each |
1,738,383 | |
| Filed 2020-06-22 17:59 Tx date 2020-06-19 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-1,696,898.576
-144,836 vol $11.72 each |
1,846,965 | |
| Filed 2020-05-27 16:56 Tx date 2020-05-25 |
$PRG
Precipitate Gold Corp. |
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$75,000
+500,000 vol $0.15 each |
500,000 | |
| Filed 2020-05-27 16:55 Tx date 2012-04-03 |
$PRG
Precipitate Gold Corp. |
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2020-05-19 12:11 Tx date 2020-05-14 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-498,050
-50,000 vol $9.96 each |
1,991,801 | |
| Filed 2020-05-19 12:10 Tx date 2020-05-14 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$372,500
+50,000 vol $7.45 each |
2,041,801 | |
| Filed 2020-05-19 12:09 Tx date 2020-05-14 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-50,000 vol |
494,438 | |
| Filed 2020-05-08 11:47 Tx date 2020-05-06 |
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Deferred share units
97 - Other
|
$
+$13,737 vol $4.87 each |
$515,154 | |
| Filed 2020-03-09 10:17 Tx date 2019-12-13 |
$ONC
Oncolytics Biotech Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,750
+35,000 vol $1.45 each |
87,893 | |
| Filed 2019-12-18 15:52 Tx date 2019-12-13 |
$ONC
Oncolytics Biotech Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,750
+35,000 vol $1.45 each |
||
| Filed 2020-02-21 15:57 Tx date 2020-02-20 |
$ONC
Oncolytics Biotech Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
+4,210 vol |
9,315 | |
| Filed 2020-02-21 15:56 Tx date 2020-02-20 |
$ONC
Oncolytics Biotech Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
57 - Exercise of rights
|
-4,210 vol |
0 | |
| Filed 2020-01-27 22:43 Tx date 2020-01-17 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+156,673 vol |
544,438 | |
| Filed 2020-01-10 22:36 Tx date 2020-01-06 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-252,149.04
-31,284 vol $8.06 each |
1,991,801 | |
| Filed 2020-01-09 23:07 Tx date 2020-01-04 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$799,898
+99,243 vol $8.06 each |
2,023,085 | |
| Filed 2020-01-09 23:07 Tx date 2020-01-04 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-99,243 vol |
99,243 | |
| Filed 2020-01-02 16:48 Tx date 2019-12-31 |
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Deferred share units
97 - Other
|
$
+$13,965 vol $1.16 each |
$501,417 | |
| Filed 2019-12-18 15:52 Tx date 2019-12-13 |
$ONC
Oncolytics Biotech Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,750
+35,000 vol $1.45 each |
87,893 | |
| Filed 2019-11-11 14:54 Tx date 2019-11-07 |
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Deferred share units
97 - Other
|
$
+$348,333 vol $0.36 each |
$487,452 | |
| Filed 2019-10-22 12:46 Tx date 2019-10-21 |
$SR
Strategic Resources Inc. |
Moore, Michael Peter
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$60,000
+240,000 vol $0.25 each |
240,000 | |
| Filed 2019-10-22 12:45 Tx date 2016-09-09 |
$SR
Strategic Resources Inc. |
Moore, Michael Peter
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-10-03 22:28 Tx date 2019-10-02 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
47 - Acquisition or disposition by gift
|
-25,000 vol |
1,923,842 | |
| Filed 2019-10-02 15:30 Tx date 2019-09-30 |
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Deferred share units
97 - Other
|
$
+$36,967 vol $0.4467 each |
$139,119 | |
| Filed 2019-07-03 14:02 Tx date 2019-06-30 |
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Deferred share units
97 - Other
|
$
+$39,114 vol $0.4358 each |
$102,152 | |
| Filed 2019-04-23 17:58 Tx date 2016-09-09 |
$STI
Strategic Resources Inc. |
Moore, Michael Peter
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
900,000 | ||
| Filed 2019-04-05 10:12 Tx date 2019-03-31 |
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Deferred share units
97 - Other
|
$
+$18,531 vol $0.92 each |
$63,038 | |
| Filed 2019-02-25 Tx date 2019-02-25 |
$ONC
Oncolytics Biotech Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
52,893 | ||
| Filed 2019-02-25 Tx date 2019-02-25 |
$ONC
Oncolytics Biotech Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Performance Share Units
00 - Opening Balance-Initial SEDI Report
|
4,210 | ||
| Filed 2019-02-25 Tx date 2019-02-25 |
$ONC
Oncolytics Biotech Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
5,105 | ||
| Filed 2019-02-25 Tx date 2019-02-25 |
$ONC
Oncolytics Biotech Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2019-01-21 Tx date 2019-01-17 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+207,226 vol |
387,765 | |
| Filed 2019-01-11 Tx date 2019-01-04 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$173,989
+31,808 vol $5.47 each |
||
| Filed 2019-01-11 Tx date 2019-01-04 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-31,808 vol |
||
| Filed 2019-01-11 Tx date 2019-01-04 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$542,859
+99,243 vol $5.47 each |
1,980,650 | |
| Filed 2019-01-11 Tx date 2019-01-04 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-99,243 vol |
198,486 | |
| Filed 2019-01-09 Tx date 2019-01-04 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
57 - Exercise of rights
|
$173,989
+31,808 vol $5.47 each |
1,913,215 | |
| Filed 2019-01-09 Tx date 2019-01-04 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-173,989.76
-31,808 vol $5.47 each |
1,881,407 | |
| Filed 2019-01-09 Tx date 2019-01-04 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
57 - Exercise of rights
|
-31,808 vol |
265,921 | |
| Filed 2019-01-02 Tx date 2018-12-28 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
47 - Acquisition or disposition by gift
|
$-195,582.705
-53,511 vol $3.65 each |
1,881,407 | |
| Filed 2018-11-23 Tx date 2016-03-04 |
$PRG
Precipitate Gold Corp. |
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$30,000
+250,000 vol $0.12 each |
600,000 | |
| Filed 2018-11-23 Tx date 2016-03-04 |
$PRG
Precipitate Gold Corp. |
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,000
+200,000 vol $0.12 each |
||
| Filed 2018-11-23 Tx date 2018-11-20 |
$PRG
Precipitate Gold Corp. |
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$40,000
+500,000 vol $0.08 each |
1,300,000 | |
| Filed 2018-11-20 Tx date 2018-11-19 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$50,193
+11,000 vol $4.56 each |
1,934,918 | |
| Filed 2018-11-09 Tx date 2018-11-08 |
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Deferred share units
97 - Other
|
$
+$29,181 vol $4.26 each |
$44,507 | |
| Filed 2018-05-18 Tx date 2018-05-17 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$43,350
+12,500 vol $3.47 each |
1,923,918 | |
| Filed 2018-03-14 Tx date 2018-03-13 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Holder: Gregory Crawford (Indirect Ownership)
|
Common Shares
10 - Acquisition or disposition in the public market
|
-3,655,193 vol |
0 | |
| Filed 2018-01-29 Tx date 2017-11-27 |
$PRG
Precipitate Gold Corp. |
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$30,800
+77,000 vol $0.40 each |
154,000 | |
| Filed 2018-01-10 Tx date 2018-01-04 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
56 - Grant of rights
|
+297,729 vol |
297,729 | |
| Filed 2018-01-10 Tx date 2017-12-21 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-01-10 Tx date 2018-01-04 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+130,539 vol |
180,539 | |
| Filed 2018-01-03 Tx date 2017-12-28 |
$PRG
Precipitate Gold Corp. |
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$1,800
+20,000 vol $0.09 each |
549,666 | |
| Filed 2017-12-23 Tx date 2017-12-21 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,911,418 | ||
| Filed 2017-12-23 Tx date 2017-12-21 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
| Filed 2017-12-23 Tx date 2017-12-21 |
$VMD
Viemed Healthcare, Inc. |
Moore, Michael
4 - Director of Issuer
Holder: Gregory Crawford (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
3,655,193 | ||
| Filed 2017-11-14 Tx date 2017-11-09 |
$TRIL
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Deferred share units
97 - Other
|
$
+$7,390 vol $12.18 each |
$15,326 | |
| Filed 2016-11-15 Tx date 2016-11-09 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Deferred share units
97 - Other
|
$90,003
+7,936 vol $11.34 each |
||
| Filed 2016-11-15 Tx date 2016-11-09 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Deferred share units
97 - Other
|
$90,003
+7,936 vol $11.34 each |
||
| Filed 2016-11-15 Tx date 2016-11-09 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Deferred share units
97 - Other
|
$
+$7,936 vol $11.34 each |
$7,936 | |
| Filed 2016-11-15 Tx date 2013-04-09 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Deferred share units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-11-14 Tx date 2016-11-09 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Deferred share units
97 - Other
|
$90,003
+7,936 vol $11.34 each |
16,567 | |
| Filed 2016-10-18 Tx date 2016-10-13 |
$PRG
Precipitate Gold Corp. |
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,000
+200,000 vol $0.25 each |
750,000 | |
| Filed 2016-05-31 Tx date 2016-05-27 |
$PRG
Precipitate Gold Corp. |
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-17,500
-70,000 vol $0.25 each |
77,000 | |
| Filed 2016-03-09 Tx date 2016-03-04 |
$PRG
Precipitate Gold Corp. |
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$24,000
+200,000 vol $0.12 each |
550,000 | |
| Filed 2015-11-20 Tx date 2015-11-19 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Deferred share units
97 - Other
|
$39,993
+2,069 vol $19.33 each |
8,631 | |
| Filed 2015-11-17 Tx date 2015-11-17 |
$OEG
ONEnergy Inc. |
Moore, Michael John
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
50 - Grant of options
|
$37,500
+75,000 vol $0.50 each |
75,000 | |
| Filed 2015-11-17 Tx date 2015-11-06 |
$OEG
ONEnergy Inc. |
Moore, Michael John
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-10-23 Tx date 2015-07-07 |
$PHM
Patient Home Monitoring Corp. |
Moore, Michael
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-10-23 Tx date 2015-07-10 |
$PHM
Patient Home Monitoring Corp. |
Moore, Michael
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+500,000 vol |
500,000 | |
| Filed 2015-08-25 Tx date 2015-06-16 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
97 - Other
|
$10,003
+340 vol $29.42 each |
||
| Filed 2015-08-25 Tx date 2015-06-16 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
97 - Other
|
$10,003
+340 vol $29.42 each |
||
| Filed 2015-08-25 Tx date 2015-05-27 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
97 - Other
|
$39,992
+1,426 vol $28.05 each |
||
| Filed 2015-08-25 Tx date 2015-05-27 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
97 - Other
|
$39,992
+1,426 vol $28.05 each |
||
| Filed 2015-08-25 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
37 - Stock split or consolidation
|
$39,998
+4,796 vol $8.34 each |
||
| Filed 2015-08-25 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
37 - Stock split or consolidation
|
$39,998
+4,796 vol $8.34 each |
||
| Filed 2015-08-25 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
37 - Stock split or consolidation
|
$-40,000.03
-143,885 vol $0.278 each |
||
| Filed 2015-08-25 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
37 - Stock split or consolidation
|
$-40,000.03
-143,885 vol $0.278 each |
||
| Filed 2015-08-25 Tx date 2015-06-16 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Deferred share units
97 - Other
|
$10,003
+340 vol $29.42 each |
6,562 | |
| Filed 2015-08-25 Tx date 2015-05-27 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Deferred share units
97 - Other
|
$39,992
+1,426 vol $28.05 each |
6,222 | |
| Filed 2015-08-25 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Deferred share units
37 - Stock split or consolidation
|
$39,998
+4,796 vol $8.34 each |
4,796 | |
| Filed 2015-08-25 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Deferred share units
37 - Stock split or consolidation
|
$-40,000.03
-143,885 vol $0.278 each |
0 | |
| Filed 2015-08-25 Tx date 2014-05-27 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Deferred share units
97 - Other
|
$40,000
+143,885 vol $0.278 each |
143,885 | |
| Filed 2015-08-25 Tx date 2013-04-09 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Deferred share units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-08-25 Tx date 2014-05-27 |
$TR
Stem Cell Therapeutics Corp. |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
97 - Other
|
$40,000
+143,885 vol $0.278 each |
||
| Filed 2015-08-25 Tx date 2014-05-27 |
$TR
Stem Cell Therapeutics Corp. |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
97 - Other
|
$40,000
+143,885 vol $0.278 each |
||
| Filed 2015-08-25 Tx date 2013-04-09 |
$TR
Stem Cell Therapeutics Corp. |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-08-25 Tx date 2013-04-09 |
$TR
Stem Cell Therapeutics Corp. |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2015-07-21 Tx date 2015-07-07 |
$PHM
Patient Home Monitoring Corp. (formerly International Health Partners Inc.) |
Moore, Michael
7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6)
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
19,114,181 | ||
| Filed 2015-06-17 Tx date 2015-06-16 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
97 - Other
|
$10,003
+340 vol $29.42 each |
6,562 | |
| Filed 2015-06-12 Tx date 2015-05-27 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
97 - Other
|
$39,992
+1,426 vol $28.05 each |
6,222 | |
| Filed 2015-05-22 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
37 - Stock split or consolidation
|
$39,998
+4,796 vol $8.34 each |
4,796 | |
| Filed 2015-05-22 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Units Deferred Share Units
37 - Stock split or consolidation
|
$-40,000.03
-143,885 vol $0.278 each |
0 | |
| Filed 2015-05-22 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
+4,000 vol |
4,000 | |
| Filed 2015-05-22 Tx date 2014-11-14 |
$TR
Trillium Therapeutics Inc. (formerly Stem Cell Therapeutics Corp.) |
Moore, Michael
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-120,000 vol |
0 | |
| Filed 2015-05-20 Tx date 2015-05-16 |
$PRG
Precipitate Gold Corp. |
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
$-16,149.90
-107,666 vol $0.15 each |
147,000 | |
| Filed 2015-05-20 Tx date 2014-05-26 |
$PRG
Precipitate Gold Corp. |
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$10,500
+70,000 vol $0.15 each |
177,666 | |
| Filed 2015-05-20 Tx date 2014-05-26 |
$PRG
Precipitate Gold Corp. |
Moore, Michael Peter
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$10,500
+70,000 vol $0.15 each |